Frontiers | Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control

Development of small molecule inhibitors and antibodies targeting AXL for tumor therapy and infectious disease control

8,720
Total downloads
29k
Total views and downloads

43 Authors

diana boraschi
Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS)
China
dong kwon kim
Severance Biomedical Science Institute, Yonsei University College of Medicine
Republic of Korea
eun kyung kim
Severance Biomedical Science Institute, Yonsei University College of Medicine
Republic of Korea
hae dong kim
Rare Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Republic of Korea
hee kyu lee
Department of Discovery Biology, Oscotec Inc.
Republic of Korea
hwan-kyu jeong
School of Biosystems and Biomedical Sciences, Korea University
Republic of Korea
hye-youn son
Department of Breast and Endocrine Surgery, Center for Medical Innovation, Seoul National University Hospital
Republic of Korea
jii bum lee
Division of Hemato-oncology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine
Republic of Korea
joo-hang kim
Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine
Republic of Korea
kyoung-ho pyo
Severance Biomedical Science Institute, Yonsei University College of Medicine
Republic of Korea
min hee hong
Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine
Republic of Korea
s. m. mazidur rahman
International Centre for Diarrhoeal Disease Research (iccdr,b)
Bangladesh

Share on

Frontiers in Oncology

Frontiers in Oncology

Pharmacology of Anti-Cancer Drugs

Participating Journals

Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- 4.4 impact factor
- 7.8 citescore

Impact

29kTopic views
19kArticle views
8,720Article downloads